Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 1, 2011, Pages 52-58

  Egashira, Nobuaki ^a,b   Shirakawa, Atsunori ^a   Okuno, Ryoko ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Oishi, Ryozo ^b   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

AMPA receptor; Behavior; Cannabinoids; Glutamate; Serotonin receptor

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; ANIRACETAM; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DIZOCILPINE; ENDOCANNABINOID; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RILUZOLE; THEANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEAD TWITCH; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; ENDOCANNABINOIDS; GLUTAMIC ACID; HEAD MOVEMENTS; MALE; MICE;

MUS;

EID: 79955459016     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.04.003     Document Type: Article

References (77)

1. P. Adamczyk, A. Gołda, A.C. McCreary, M. Filip, and E. Przegaliński Activation of endocannabinoid transmission induces antidepressant-like effects in rats J Physiol Pharmacol 59 2008 217 228 (Pubitemid 351955748)
2. B.W. Adams, and B. Moghaddam Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex Biol Psychiatry 50 2001 750 757 (Pubitemid 33086762)
3. M. Amargós-Bosch, X. López-Gil, F. Artigas, and A. Adell Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine Int J Neuropsychopharmacol 9 2006 565 573 (Pubitemid 44607209)
4. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152 (Pubitemid 29292403)
5. 2A receptor antagonist Eur J Pharmacol 473 2003 229 230 (Pubitemid 36929889)
6. M.A. Benneyworth, Z. Xiang, R.L. Smith, E.E. Garcia, P.J. Conn, and E. Sanders-Bush A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis Mol Pharmacol 72 2007 477 484 (Pubitemid 47124127)
7. M. Bortolato, P. Campolongo, R.A. Mangieri, M.L. Scattoni, R. Frau, and V. Trezza Anxiolytic-like properties of the anandamide transport inhibitor AM404 Neuropsychopharmacology 31 2006 2652 2659 (Pubitemid 44764162)
8. 9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats Eur J Pharmacol 555 2007 156 163 (Pubitemid 46048802)
9. C.E. Canal, U.B. Olaghere da Silva, P.J. Gresch, E.E. Watt, E. Sanders-Bush, and D.C. Airey The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen Psychopharmacology (Berl) 209 2010 163 174
10. J.M. Cleghorn, E.S. Garnett, C. Nahmias, G. Firnau, G.M. Brown, and R. Kaplan Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia Psychiatry Res 28 1989 119 133 (Pubitemid 19144984)
11. F.C. Colpaert Discovering risperidone: the LSD model of psychopathology Nat Rev Drug Discov 2 2003 315 320 (Pubitemid 37361689)
12. P.J. Conn, C.W. Lindsley, and C.K. Jones Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia Trends Pharmacol Sci 30 2009 25 31
13. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, and B.R. Martin Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci USA 98 2001 9371 9376 (Pubitemid 32743923)
14. R. Dall'Olio, R. Gaggi, V. Bonfante, and O. Gandolfi The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function Behav Pharmacol 10 1999 63 71 (Pubitemid 29106289)
15. 2A receptor-mediated behaviors in mice Pharmacol Biochem Behav 68 2001 311 317 (Pubitemid 32231193)
16. 1 receptor antagonist SR 141716A in naive mice J Neural Transm 107 2000 931 945
17. 2 receptors? Pharmacol Biochem Behav 36 1990 901 906 (Pubitemid 20272314)
18. N. De Marchi, L. De Petrocellis, P. Orlando, F. Daniele, F. Fezza, and V. Di Marzo Endocannabinoid signaling in the blood of patients with schizophrenia Lipids Health Dis 2 2003 5 13
19. 3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use Neuroscience 103 2001 9 15 (Pubitemid 32304342)
20. N. Egashira, K. Hayakawa, K. Mishima, H. Kimura, K. Iwasaki, and M. Fujiwara Neuroprotective effect of γ-glutamylethylamide (theanine) on cerebral infarction in mice Neurosci Lett 363 2004 58 61 (Pubitemid 38639851)
21. N. Egashira, K. Mishima, T. Uchida, N. Hasebe, H. Nagai, and A. Mizuki Anandamide inhibits the DOI-induced head-twitch response in mice Psychopharmacology 171 2004 382 389 (Pubitemid 38200049)
22. N. Egashira, R. Okuno, S. Harada, M. Matsushita, K. Mishima, and K. Iwasaki Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder Eur J Pharmacol 586 2008 164 170
23. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, and G. Tarzia Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 2005 352 358 (Pubitemid 40411361)
24. J.C. Gewirtz, and G.J. Marek Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors Neuropsychopharmacology 23 2000 569 576
25. A. Giuffrida, F.M. Leweke, C.W. Gerth, D. Schreiber, D. Koethe, and J. Faulhaber Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms Neuropsychopharmacology 29 2004 2108 2114 (Pubitemid 39486563)
26. 2 agonists or antagonists? Neuropsychopharmacology 3 1990 509 517
27. G. Gobbi, F.R. Bambico, R. Mangieri, M. Bortolato, P. Campolongo, and M. Solinas Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis Proc Natl Acad Sci USA 102 2005 18620 18625 (Pubitemid 43011275)
28. J.P. Gong, E.S. Onaivi, H. Ishiguro, Q.R. Liu, P.A. Tagliaferro, and A. Brusco Cannabinoid CB2 receptors: immunohistochemical localization in rat brain Brain Res 1071 2006 10 23 (Pubitemid 43255471)
29. J. González-Maeso, T. Yuen, B.J. Ebersole, E. Wurmbach, A. Lira, and M. Zhou Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex J Neurosci 23 2003 8836 8843 (Pubitemid 37210895)
30. 2A receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452 (Pubitemid 46161267)
31. B.B. Gorzalka, M.N. Hill, and J.C. Sun Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes Eur J Pharmacol 516 2005 28 33 (Pubitemid 40780115)
32. E. Gouzoulis-Mayfrank, K. Heekeren, A. Neukirch, M. Stoll, C. Stock, and M. Obradovic Psychological effects of (S)-ketamine and N, N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers Pharmacopsychiatry 38 2005 301 311 (Pubitemid 41815687)
33. S. Haj-Dahmane, and R.Y. Shen Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors J Pharmacol Exp Ther 331 2009 186 196
34. R.L. Hayslett, and Y. Tizabi Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome Pharmacol Biochem Behav 81 2005 879 886 (Pubitemid 41187823)
35. 1 receptor activity elicits an antidepressant-like response in the rat forced swim test Eur Neuropsychopharmacol 15 2005 593 599 (Pubitemid 41587409)
36. 3H]MDL 105,519 to glutamate receptors Biosci Biotechnol Biochem 66 2002 2683 2686 (Pubitemid 39251144)
37. 3H]glutamine transport in neurons and astroglia in rat brain J Neurosci Res 86 2008 1846 1856 (Pubitemid 351859434)
38. R.D. Kaplan, H. Szechtman, S. Franco, B. Szechtman, C. Nahmias, and E.S. Garnett Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET) Schizophr Res 11 1993 47 54 (Pubitemid 23363165)
39. 2 receptor-mediated behavior, head-twitch response, in mice Life Sci 63 1998 2305 2311
40. A. Kłodzinska, M. Bijak, K. Tokarski, and A. Pilc Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice Pharmacol Biochem Behav 73 2002 327 332 (Pubitemid 34765571)
41. F.M. Leweke, A. Giuffrida, U. Wurster, H.M. Emrich, and D. Piomelli Elevated endogenous cannabinoids in schizophrenia Neuroreport 10 1999 1665 1669 (Pubitemid 29354290)
42. J.A. Lieberman, R.B. Mailman, G. Duncan, L. Sikich, M. Chakos, and D.E. Nichols Serotonergic basis of antipsychotic drug effects in schizophrenia Biol Psychiatry 44 1998 1099 1117 (Pubitemid 28547145)
43. X. López-Gil, Z. Babot, M. Amargós-Bosch, C. Suñol, F. Artigas, and A. Adell Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat Neuropsychopharmacology 32 2007 2087 2097 (Pubitemid 47417703)
44. D.S. Lorrain, C.S. Baccei, L.J. Bristow, J.J. Anderson, and M.A. Varney Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 Neuroscience 117 2003 697 706 (Pubitemid 36263162)
45. 1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats Neuropharmacology 56 2009 1082 1087
46. 2A and group II metabotropic glutamate receptors in prefrontal cortex J Pharmacol Exp Ther 292 2000 76 87 (Pubitemid 30026356)
47. P. Martin, M.L. Carlsson, and S. Hjorth Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats Neuroreport 9 1998 2985 2988 (Pubitemid 28555632)
48. R. Martín-Ruiz, M.V. Puig, P. Celada, D.A. Shapiro, B.L. Roth, and G. Mengod Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism J Neurosci 21 2001 9856 9866 (Pubitemid 34184070)
49. 3H] MK801 binding to synaptic membranes from rat central nervous system Comp Biochem Physiol 107C 1994 105 110 (Pubitemid 24080884)
50. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
51. S. Miyamoto, G.E. Duncan, C.E. Marx, and J.A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol Psychiatry 10 2005 79 104 (Pubitemid 40139590)
52. B. Moghaddam, B. Adams, A. Verma, and D. Daly Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neurosci 17 1997 2921 2927 (Pubitemid 27155025)
53. F.A. Moreira, N. Kaiser, K. Monory, and B. Lutz Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors Neuropharmacology 54 2008 141 150 (Pubitemid 350299416)
54. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
55. K. Nakamura, M. Kurasawa, and M. Shirane Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats Brain Res 862 2000 266 269 (Pubitemid 30229798)
56. S. Patel, and C.J. Hillard Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling J Pharmacol Exp Ther 318 2006 304 311
57. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, and B.V. Andreev Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat Med 13 2007 1102 1107 (Pubitemid 47517511)
58. R.G. Pertwee, and R.A. Ross Cannabinoid receptors and their ligands Prostaglandins Leukot Essent Fatty Acids 66 2002 101 121 (Pubitemid 34743589)
59. 2A/C receptor-mediated behavior Psychopharmacology (Berl) 190 2007 221 231 (Pubitemid 46011182)
60. R.A. Ross Anandamide and vanilloid TRPV1 receptors Br J Pharmacol 140 2003 790 801 (Pubitemid 37464060)
61. T. Rubino, N. Realini, C. Castiglioni, C. Guidali, D. Viganó, and E. Marras Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex Cereb Cortex 18 2008 1292 1301 (Pubitemid 351769783)
62. M. Rutkowska, J. Jamontt, and H. Gliniak Effects of cannabinoids on the anxiety-like response in mice Pharmacol Rep 58 2006 200 206
63. A. Saber-Tehrani, N. Naderi, A. Hosseini Najarkolaei, A. Haghparast, and F. Motamedi Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice. Neurochem Res 35 2010 60 66
64. 2C inverse agonist, SR46349B Psychopharmacology (Berl) 213 2011 393 401
65. 2A heteroceptors on thalamocortical glutamatergic neurons J Neurosci 20 2000 8846 8852
66. J.L. Scruggs, D. Schmidt, and A.Y. Deutch The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats Neurosci Lett 346 2003 137 140 (Pubitemid 36829280)
67. A. Seillier, T. Advani, T. Cassano, J.G. Hensler, and A. Giuffrida Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats Int J Neuropsychopharmacol 17 2009 1 14
68. E.T. Tzavara, D.L. Li, L. Moutsimilli, T. Bisogno, V. Di Marzo, and L.A. Phebus Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications Biol Psychiatry 59 2006 508 515 (Pubitemid 43320538)
69. H. Ujike, and Y. Morita New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia J Pharmacol Sci 96 2004 376 381 (Pubitemid 40144054)
70. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, and K. Mackie Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
71. 18F]fluorodeoxyglucose (FDG) Eur Neuropsychopharmacol 7 1997 9 24 (Pubitemid 27139716)
72. F.X. Vollenweider, M.F. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport 9 1998 3897 3902 (Pubitemid 29189323)
73. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats J Pharmacol Exp Ther 282 1997 699 706 (Pubitemid 27340170)
74. T. Yamada, T. Terashima, S. Kawano, R. Furuno, T. Okubo, and L.R. Juneja Theanine, γ-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats Amino Acids 36 2009 21 27
75. 1 receptors is increased in the anterior cingulate cortex in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 28 2004 355 360 (Pubitemid 38130143)
76. Y. Zhai, C.A. George, J. Zhai, E.S. Nisenbaum, M.P. Johnson, and L.K. Nisenbaum Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex Neuropsychopharmacology 28 2003 45 52
77. 2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes Prog Neuropsychopharmacol Biol Psychiatry 32 2008 62 71